Pulmonary function testing in COPD: looking beyond the curtain of FEV1
Abstract Chronic obstructive pulmonary disease (COPD) management remains challenging due to the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the disease. Airflow limitation, diagnosed by spirometry, remains the cornerstone of the diagnosis. However, the calcula...
Enregistré dans:
Auteurs principaux: | Sotirios Kakavas, Ourania S. Kotsiou, Fotis Perlikos, Maria Mermiri, Georgios Mavrovounis, Konstantinos Gourgoulianis, Ioannis Pantazopoulos |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cc06a18eb8ea416582606caa139086d6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis
par: Evdoxia Gogou, et autres
Publié: (2021) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
par: Jafar Aljazeeri, et autres
Publié: (2021) -
PeakPCO combined with FEV1/FVC predicts vasodilator-responsive patients with idiopathic pulmonary arterial hypertension
par: Ci-Jun Luo, et autres
Publié: (2021) -
FeV1 and BMI influence King’s Sarcoidosis Questionnaire score in sarcoidosis patients
par: Björn Christian Frye, et autres
Publié: (2021) -
Mepolizumab and COPD in Real Life
par: Fernando Revuelta-Salgado, et autres
Publié: (2022)